Q1 EPS Estimates for Stoke Therapeutics Increased by Wedbush
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Stock analysts at Wedbush lifted their Q1 2025 earnings per share (EPS) estimates for shares of Stoke Therapeutics in a research note issued on Tuesday, March 18th. Wedbush analyst L. Chico now anticipates that the company will post earnings per share of ($0.57) for the quarter, up […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Stock analysts at Wedbush lifted their Q1 2025 earnings per share (EPS) estimates for shares of Stoke Therapeutics in a research note issued on Tuesday, March 18th. Wedbush analyst L. Chico now anticipates that the company will post earnings per share of ($0.57) for the quarter, up […]
